M. Murakami et al., IDENTIFICATION AND CHARACTERIZATION OF AN ALTERNATIVE CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN-4 BINDING MOLECULE ON B-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 7838-7842
To determine whether alternative cytotoxic T lymphocyte-associated pro
tein 4 (CTLA4) binding proteins exist on B cells, we constructed (i) m
CTLA4hIgG consisting of the extracellular region of a mouse CTLA4 mole
cule and the Fc portion of a human IgG1 molecule and (ii) PYAAhIgG, a
mutant mCTLA4hIgG, having two amino acid substitutions on the conserve
d MYPPPY motif in the complementarity-determining region 3-like region
and lacking detectable binding to both B7-1 and B7-2 molecules. Using
these fusion proteins (mCTLA4hIgG and PYAAhIgG), we demonstrated that
a mouse immature B-cell line, WEH1231 cells, expressed alternative CT
LA4 binding molecules (ACBMs) that were distinct from both B7-1 and B7
-2. ACBMs were 130-kDa disulfide-linked proteins. More importantly, AC
BMs were able to provide costimulatory signal for T-cell proliferation
in the presence of anti-CD3 monoclonal antibodies. In addition, we de
monstrated that more than 20% of B220(+) cells obtained from normal mo
use spleen expressed ACBMs.